{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:34:47Z","timestamp":1791178487073,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/rlu.0b013e3182872f0e","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T21:32:20Z","timestamp":1363987940000},"page":"422-425","source":"Crossref","is-referenced-by-count":32,"title":["Variation of Liver SUV on 18FDG-PET\/CT Studies in Women With Breast Cancer"],"prefix":"10.1097","volume":"38","author":[{"given":"David","family":"Groheux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Delord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Colletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh-Loan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Hindi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210204","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00259-010-1660-5","article-title":"Early monitoring of response to neoadjuvant chemotherapy in breast cancer with (18)F-FDG PETCT: defining a clinical aim.","volume":"38","author":"Groheux","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R2-5-20210204","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2967\/jnumed.111.094045","article-title":"Triple-negative breast cancer: early assessment with 18F-FDG PETCT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathologic complete response and are at a high risk of early relapse.","volume":"53","author":"Groheux","year":"2012","journal-title":"J Nucl Med"},{"issue":"suppl 1","key":"R3-5-20210204","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors.","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"R4-5-20210204","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2967\/jnumed.110.080556","article-title":"Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference background.","volume":"51","author":"Itti","year":"2010","journal-title":"J Nucl Med"},{"key":"R5-5-20210204","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00259-010-1490-5","article-title":"Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.","volume":"37","author":"Barrington","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R6-5-20210204","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3109\/10428194.2012.677535","article-title":"Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus.","volume":"53","author":"Meignan","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"suppl 2","key":"R7-5-20210204","first-page":"S236","article-title":"Assessment of response after two cycles of neoadjuvant chemotherapy in locally advanced breast cancer using FDG PETCT.","volume":"37","author":"Groheux","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R8-5-20210204","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease.","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"R9-5-20210204","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11307-008-0177-9","article-title":"Increasing uptake time in FDG-PET: standardized uptake values in normal tissues at 1 versus 3 h.","volume":"11","author":"Chin","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"R10-5-20210204","first-page":"1044","article-title":"SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.","volume":"44","author":"Beaulieu","year":"2003","journal-title":"J Nucl Med"},{"key":"R11-5-20210204","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2967\/jnumed.110.077461","article-title":"Time course of tumor SUV in 18F-FDG PET of breast cancer: presentation of a simple model using a single reference point for time corrections of tumor SUVs.","volume":"52","author":"Stahl","year":"2011","journal-title":"J Nucl Med"},{"key":"R12-5-20210204","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2967\/jnumed.109.074104","article-title":"Variations in PETCT methodology for oncologic imaging at U.S. academic medical centers: an imaging response assessment team survey.","volume":"52","author":"Graham","year":"2011","journal-title":"J Nucl Med"},{"key":"R13-5-20210204","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nucmedbio.2010.09.004","article-title":"Effects of blood glucose level on FDG uptake by liver: a FDG-PETCT study.","volume":"38","author":"Kubota","year":"2011","journal-title":"Nucl Med Biol"},{"key":"R14-5-20210204","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12149-009-0338-1","article-title":"Associations between liver (18)F fluoro-2-deoxy-D-glucose accumulation and various clinical parameters in a Japanese population: influence of the metabolic syndrome.","volume":"24","author":"Kamimura","year":"2010","journal-title":"Ann Nucl Med"},{"key":"R15-5-20210204","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00259-007-0459-5","article-title":"18FFDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy.","volume":"34","author":"Berriolo-Riedinger","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R16-5-20210204","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clinimag.2009.11.003","article-title":"Impact of age on FDG uptake in the liver on PET scan.","volume":"34","author":"Lin","year":"2010","journal-title":"Clin Imaging"},{"key":"R17-5-20210204","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00259-010-1640-9","article-title":"Correlation of high (18)F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.","volume":"38","author":"Groheux","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0b013e3182872f0e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:29:44Z","timestamp":1621884584000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201306000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e3182872f0e","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}